Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
株式のランク #31255
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
株価
$0.39
時価総額
$13.79M
変化(1日)
-13.53%
変化(1年)
-68.80%
IL
取引 NeuroSense Therapeutics Ltd. (NRSN)

カテゴリー

NeuroSense Therapeutics Ltd.(NRSN)の株価履歴
終値の最高値: $0.47 (2026-08-01)

終値の最安値: $3.04 (2021-12-01)
NeuroSense Therapeutics Ltd. の株価履歴(2021 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -1.04%
2025 -17.69%
2024 31.68%
2023 -42.23%
2022 -51.82%
2021 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$527.89 35.40%
US
$996.61 50.70%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE